Dayanne Tomaz Casimiro da Silva

Dr. Dayanne Tomaz Casimiro da Silva

Universidade Federal de Pernambuco
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Microporous and Mesoporous Materials
Verified
Journal Article
Closed access
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
Maria FonsecaMaria Fonseca
Maria Fonseca
ABAna Borrego-Sánchez
Ana Borrego-Sánchez
MSMonica F. L. R. Soares
Monica F. L. R. Soares
CVCésar Viseras
César Viseras
JSJosé Lamartine Soares Sobrinho
José Lamartine Soares Sobrinho

1 January 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SCShayara Lopes Ciríaco
Shayara Lopes Ciríaco
ICIvana Pereira Santos Carvalho
Ivana Pereira Santos Carvalho
JNJosé Alves Terceiro Neto
José Alves Terceiro Neto
JNJosé de Sousa Lima Neto
José de Sousa Lima Neto
DODaniel Henrique Bento de Oliveira
Daniel Henrique Bento de Oliveira
ACAndré Luis Menezes Carvalho
André Luis Menezes Carvalho

31 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VMVandiara Martins Moreira
Vandiara Martins Moreira
JLJoandra Maísa Silva Leite
Joandra Maísa Silva Leite
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
KAKaroll Moangella Andrade de Assis
Karoll Moangella Andrade de Assis
JBJoyce Cordeiro Borges
Joyce Cordeiro Borges
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
This study aimed to develop films of chitosan (CSF) associated with pentoxifylline (PTX) for healing cutaneous wounds. These films were prepared at two concentrations, F1 (2.0 mg/mL) and F2 (4.0 mg/mL), and the interactions between the materials, structural characteristics, in vitro release, and morphometric aspects of skin wounds in vivo were evaluated. The formation of the CSF film with acetic acid modifies the polymeric structure, and the PTX demonstrates interaction with the CSF, in a semi-crystalline structure, for all concentrations. The release for all films was proportional to the concentration, with two phases: a fast one of ≤2 h and a slow one of >2 h, releasing 82.72 and 88.46% of the drug after 72 h, being governed by the Fickian diffusion mechanism. The wounds of the mice demonstrate a reduction of up to 60% in the area on day 2 for F2 when compared to CSF, F1, and positive control, and this characteristic of faster healing speed for F2 continues until the ninth day with wound reduction of 85%, 82%, and 90% for CSF, F1, and F2, respectively. Therefore, the combination of CSF and PTX is effective in their formation and incorporation, demonstrating that a higher concentration of PTX accelerates skin-wound reduction.

4 July 2023 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
IAIgor Eduardo Silva Arruda
Igor Eduardo Silva Arruda
JOJabson Herber Profito de Oliveira
Jabson Herber Profito de Oliveira
BDBolivar Ponciano Goulart de Lima Damasceno
Bolivar Ponciano Goulart de Lima Damasceno
MSMônica Felts de La Roca Soares
Mônica Felts de La Roca Soares
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
JSJosé Lamartine Soares-Sobrinho
José Lamartine Soares-Sobrinho

1 January 2024 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
ASAna Beatriz Almeida de Sousa Silva
Ana Beatriz Almeida de Sousa Silva
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Leishmaniasis is a neglected disease caused by the parasite of the genus Leishmania. Current treatment regimens are obsolete and cause several side effects, promoting poor patient compliance, in addition to the vast majority already having the potential for resistance. Therefore, polymeric nanoparticles emerge as one of the viable alternatives to overcome existing limitations, through passive or active vectorization. This review aims to summarize the latest studies of polymeric nanoparticles as an alternative treatment for leishmaniasis. In the first section, the main pharmacokinetic and pharmacodynamic challenges of current drugs are reported. The second section details how nanoparticles with and without functionalization are efficient in the treatment of leishmaniasis, discussing the characteristics of the polymer in the formulation. In this way, polymeric nanoparticles can improve the physicochemical properties of leishmanicidal drugs, improving solubility and stability, as well as improve the release of these drugs, directly or indirectly reaching monocytes/macrophages. 64.28% drugs were focused on the treatment of visceral leishmaniasis, and 28.57% on cutaneous leishmaniasis. The most chosen polymers in the literature are chitosan (35.71%) and PLGA (35.71%), the others represented 14.30% drugs, with all able to manage the drug release and increase the in vitro and/or in vivo efficacy of the original molecule. However, there are several barriers for these nanoformulations to cross laboratory research and is necessary more in-depth studies about the metabolites and degradation pathways of the polymers used in the formulations and plasma proteomics studies.

22 September 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JNJonas Lira Do Nascimento
Jonas Lira Do Nascimento
MCMichely Costa
Michely Costa
LMLeticia Farias de Macêdo
Leticia Farias de Macêdo
LMLuiz Henrique Chaves de Macêdo
Luiz Henrique Chaves de Macêdo
RMRicardo Olímpio de Moura
Ricardo Olímpio de Moura
Dayanne Tomaz Casimiro da SilvaDayanne Tomaz Casimiro da Silva
Dayanne Tomaz Casimiro da Silva
Background/Objectives: Silver sulfadiazine (AgSD) is widely used in the topical treatment of burns and infected wounds, but its conventional formulations present drawbacks such as poor water solubility, the need for multiple daily applications, and patient discomfort. To overcome these limitations, this study aimed to develop and evaluate Laponite® (LAP)-based hydrogels loaded with AgSD for controlled release and enhanced antimicrobial and antibiofilm efficacy, offering a promising alternative for the treatment of contaminated or biofilm-forming wounds. Methods: Laponite®-based hydrogels containing 1% and 1.2% AgSD (LAP@AgSD) were prepared using a one-pot method. The formulations were characterized rheologically, thermally, and structurally. In vitro drug release was assessed using Franz diffusion cells, and mathematical modeling was applied to determine release kinetics. Antibacterial and antibiofilm activities were evaluated against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa using standardized microbiological methods. Results: LAP@AgSD hydrogels exhibited pseudoplastic behavior, high structural integrity, and enhanced thermal stability. In vitro release assays revealed a sustained release profile, best fitted by the Weibull model, indicating diffusion-controlled mechanisms. Antibacterial assays demonstrated concentration-dependent activity, with LAP@AgSD 1.2% showing superior efficacy over LAP@AgSD 1% and comparable performance to the commercial silver sulfadiazine cream (CC-AgSD). Biofilm inhibition was significant for all formulations, with CC-AgSD 1% exhibiting the highest immediate activity, while LAP@AgSD 1.2% provided sustained antibiofilm potential. Conclusions: LAP-based hydrogels are promising smart delivery systems for AgSD, combining mechanical robustness, controlled drug release, and effective antibacterial and antibiofilm activities. These findings support their potential use in topical therapies for infected and chronic wounds, particularly where biofilm formation is a challenge.